Silo Pharma
  • Home
  • About
  • Our Pipeline
  • Study
  • Investors
  • Contact Us
Select Page
Investor relations
  • Overview
  • News & Events
    • Events
    • Press Releases
  • Stock Info
  • SEC Filings
  • Governance
    • Board of Directors
    • Our Team
  • Scientific Advisory Board
  • FAQs
  • Email Alerts

Events


    Past Events

    • 7th Annual Dawson James Small Cap Growth Conference (October 12, 2022 2:30 PM ET)
    Silo Pharma

    Silo Pharma

    Focused on merging traditional therapeutics with psychedelic research to innovatively address underserved conditions including Fibromyalgia, PTSD, Alzheimer's, and other rare neurological disorders. Silo’s mission is to identify assets to license and fund the research which we believe will be transformative to the well-being of patients and the healthcare industry.

    Company

    • Home
    • Team
    • Advisory Board
    • Contact Us

    Drug Pipeline

    • SPC-14
    • SPC-15
    • SP-26
    • SPU-16
    • SPU-21

    Clinical Studies

    • Effect of Psilocybin on Inflammation in the Blood

    Investors

    • Stock Information
    • SEC Filings
    • Board of Directors
    • Latest News
    • Email Alerts
    © 2023 Silo Pharma, Inc. All Rights Reserved
    Terms & ConditionsPrivacy Policy
    Corporate Governance

    Reports Regarding LMP Automotive Holdings’ Accounting or Auditing Matters or Other Concerns and Communications with the Board of Directors.

    Shareholders and interested parties may communicate directly with the Board of Directors, the Audit Committee of the Board of Directors with respect to accounting issues, questionable accounting or auditing matters or internal accounting controls, any other Board committee, any individual Director, any group of Directors or the Lead Independent Director by e-mailing businessethics@lmpah.com.

    Reports may be made anonymously or confidentially.

    Disclaimer

    You are about to review presentations, reports and/or filings of Silo Pharma, Inc. , that contain time-sensitive information. The information contained therein is only accurate as of the date thereof. Silo Pharma, Inc. will not be reviewing or updating the material that is contained in these items after the date thereof. The information contained therein may be updated, amended, supplemented or otherwise altered by subsequent presentations, reports and/or filings by Silo Pharma, Inc.

    I Accept I Decline